AMERICAN SHARED HOSPITAL SER (AMS)
US0295951059 - Common Stock
We assign a fundamental rating of 5 out of 10 to AMS. AMS was compared to 117 industry peers in the Health Care Providers & Services industry. While AMS is still in line with the averages on profitability rating, there are concerns on its financial health. AMS is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
AMS had positive earnings in the past year.
AMS had a positive operating cash flow in the past year.
Of the past 5 years AMS 4 years were profitable.
Each year in the past 5 years AMS had a positive operating cash flow.
1.2 Ratios
AMS has a better Return On Assets (1.28%) than 62.07% of its industry peers.
The Return On Equity of AMS (2.72%) is better than 65.52% of its industry peers.
With a decent Return On Invested Capital value of 4.92%, AMS is doing good in the industry, outperforming 62.93% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for AMS is below the industry average of 8.59%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.28% | ||
| ROE | 2.72% | ||
| ROIC | 4.92% |
ROA(3y)1.57%
ROA(5y)-2.05%
ROE(3y)3.27%
ROE(5y)-4.86%
ROIC(3y)5.3%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of AMS (2.88%) is better than 71.55% of its industry peers.
AMS's Profit Margin has declined in the last couple of years.
AMS's Operating Margin of 10.91% is amongst the best of the industry. AMS outperforms 87.07% of its industry peers.
AMS's Operating Margin has declined in the last couple of years.
AMS has a Gross Margin of 43.82%. This is in the better half of the industry: AMS outperforms 72.41% of its industry peers.
AMS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.91% | ||
| PM (TTM) | 2.88% | ||
| GM | 43.82% |
OM growth 3YN/A
OM growth 5Y-9.27%
PM growth 3YN/A
PM growth 5Y-11.18%
GM growth 3Y20.48%
GM growth 5Y2.89%
2. Health
2.1 Basic Checks
AMS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AMS has been increased compared to 1 year ago.
The number of shares outstanding for AMS has been increased compared to 5 years ago.
AMS has a worse debt/assets ratio than last year.
2.2 Solvency
AMS has an Altman-Z score of 1.40. This is a bad value and indicates that AMS is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.40, AMS perfoms like the industry average, outperforming 45.69% of the companies in the same industry.
AMS has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
AMS has a Debt to Equity ratio (0.49) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.4 |
ROIC/WACC0.62
WACC7.97%
2.3 Liquidity
AMS has a Current Ratio of 1.90. This is a normal value and indicates that AMS is financially healthy and should not expect problems in meeting its short term obligations.
AMS's Current ratio of 1.90 is fine compared to the rest of the industry. AMS outperforms 73.28% of its industry peers.
A Quick Ratio of 1.90 indicates that AMS should not have too much problems paying its short term obligations.
The Quick ratio of AMS (1.90) is better than 76.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.9 | ||
| Quick Ratio | 1.9 |
3. Growth
3.1 Past
The earnings per share for AMS have decreased strongly by -55.55% in the last year.
AMS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -10.91% yearly.
Looking at the last year, AMS shows a small growth in Revenue. The Revenue has grown by 7.99% in the last year.
The Revenue has been growing slightly by 1.59% on average over the past years.
EPS 1Y (TTM)-55.55%
EPS 3YN/A
EPS 5Y-10.91%
EPS growth Q2Q50%
Revenue 1Y (TTM)7.99%
Revenue growth 3Y6.13%
Revenue growth 5Y1.59%
Revenue growth Q2Q13.06%
3.2 Future
AMS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 189.83% yearly.
AMS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.52% yearly.
EPS Next Y540%
EPS Next 2Y189.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year35.13%
Revenue Next 2Y23.52%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
AMS is valuated quite expensively with a Price/Earnings ratio of 33.83.
Based on the Price/Earnings ratio, AMS is valued a bit cheaper than 62.93% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 24.67. AMS is valued slightly more expensive when compared to this.
Based on the Price/Forward Earnings ratio of 9.42, the valuation of AMS can be described as reasonable.
Based on the Price/Forward Earnings ratio, AMS is valued cheaply inside the industry as 94.83% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 21.02. AMS is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.83 | ||
| Fwd PE | 9.42 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, AMS is valued cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 2.83 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of AMS may justify a higher PE ratio.
A more expensive valuation may be justified as AMS's earnings are expected to grow with 189.83% in the coming years.
PEG (NY)0.06
PEG (5Y)N/A
EPS Next 2Y189.83%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for AMS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AMERICAN SHARED HOSPITAL SER
NYSEARCA:AMS (4/30/2024, 7:04:00 PM)
3.0445
-0.21 (-6.32%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap19.27M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.83 | ||
| Fwd PE | 9.42 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.06
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.28% | ||
| ROE | 2.72% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 10.91% | ||
| PM (TTM) | 2.88% | ||
| GM | 43.82% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.9 | ||
| Quick Ratio | 1.9 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-55.55%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y540%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)7.99%
Revenue growth 3Y6.13%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y